SG

Steve Gelsi

Questioning terms, Oregon fails to back Warburg Pincus energy pool

A proposed commitment to the Warburg Pincus Energy Fund failed to win approval by the Oregon Investment Council after the manager of the $70 billion state pension system raised questions over its economic terms.

3 min read · 02 May 2014

Carlyle Opportunity pool two-thirds invested

With its latest flagship fund tipping the scales at $13 billion and a growing stable of buyout vehicles cutting across categories and geographies, The Carlyle Group still maintains a focus on mid-market deals with its Carlyle Equity Opportunity Fund.

4 min read · 02 May 2014

Carlyle running ahead of fundraising target for 2014

Carlyle Group said it raised $5.5 billion in capital for various funds in the first quarter, putting the firm on pace to exceed its target of $15 billion to $20 billion in fresh capital for 2014, according to the firm’s first-quarter conference call with analysts.

3 min read · 30 April 2014

Goldman Sachs: $9 billion portfolio subject to Volcker Rule

Goldman Sachs Group is currently managing about $9 billion in alternative funds—mostly private equity investments—that need to be addressed for the marquee investment bank to comply with capital requirements under the Volcker Rule, according to a recent update from the firm’s chief financial officer.

3 min read · 30 April 2014

Spire Capital raises $133 mln for Fund III

Spire Capital Partners said it raised $133 million for Spire Capital Partners III LP, including an investment from Teacher Retirement System of Texas’s emerging managers program, according to a regulatory filing for the New York-based lower mid-market buyout firm.

2 min read · 29 April 2014

Hamilton Lane closes on $427 mln for new FoF

Hamilton Lane said it held a final close on its eighth fund of funds with $426.8 million in commitments, beating its target of $400 million, in a fundraising process that took at least 18 months.

2 min read · 29 April 2014

Talking Deal Prices with Steve Gelsi: Biomet's 1.4x return for sponsors trumps IPO; newspapers as contrarian play

The buyout of Biomet Group by strategic competitor Zimmer Holdings Inc, valued at $13.35 billion, has trumped plans by the orthopedic medical device firm’s sponsors to take the firm public. The deal is in line to deliver healthy gains, despite the purchase price paid for Biomet at a time of frothy transactions for private equity consortia.

3 min read · 29 April 2014

Hamilton Lane closes on $427 mln for new FoF

2 min read · 29 April 2014

Ardian closes $10 billion secondary fund at hard cap after AXA spinout: UPDATED

Ardian said it drew $10 billion in commitments for Ardian Secondary Fund VI, which includes $1 billion for primary investments, in what may be the largest secondary fund ever raised and the firm’s first since changing its name from AXA Private Equity.

2 min read · 25 April 2014

One Rock Capital closes debut fund at $432 million after Ripplewood spinout

One Rock Capital Partners LLC, launched in 2010 by two veterans of Ripplewood Holdings, wrapped up fundraising for its debut buyout pool, One Rock Capital Partners LP, at $432 million, above its $300 million target, as the New York firm takes aim at controlling stakes in lower mid-market companies in North America with backing from Mitsubishi Corp.

2 min read · 25 April 2014

Showing 941 to 950 of 1,294 results
1…9496…130